OR WAIT null SECS
September 09, 2020
The investment at its Madison, WI, facility will expand MilliporeSigma’s capacity for high-potent active pharmaceutical ingredient production and allow for continuous flow manufacturing of ADCs.
The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.
September 03, 2020
Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain.
August 24, 2020
Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.
August 21, 2020
CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2.
August 14, 2020
Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
August 03, 2020
Particle engineering is a useful tool to manipulate API particles into a form that is manufacturable and deliverable to the patient.
August 02, 2020
The early success seen on the market for approved cell and gene therapies poses both technical and manufacturing challenges for pipeline candidates on the road to commercialization.
August 01, 2020
Contract service providers offer vital services to bio/pharma companies of all sizes. Establishing an effective working relationship and managing operations are key to avoiding compliance issues.